share_log

Market-Moving News May 2nd

Benzinga ·  May 2 20:39

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.

LUNG: 29% | Pulmonx shares are trading higher after the company reported better-than-expected Q1 financial results.

EBS: 83% | Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment